Albert T.A. Mairuhu - Concepedia

Author

Albert T.A. Mairuhu

Also Known As

A T A Mairuhu, A. Mairuhu, A. T. A. Mairuhu, A.T.A Mairuhu, A.T.A. MAIRUHU, A.T.A. Mairuhu, Albert Mairuhu, Albert T A Mairuhu, Albert T. A. Mairuhu, Albert T. Mairuhu

Publications

3.5K

Citations

H-Index

Concepts

All Affiliations

Slotervaartziekenhuis Haga Hospital Leiden University Medical Center Amsterdam UMC Location University of Amsterdam Erasmus MC

About

Albert T.A. Mairuhu is an author at Slotervaartziekenhuis specializing in medicine, public health, and pulmonary embolism.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	920
2	Public Health	9	9	876
3	Emergency Medicine	5	5	656
4	Epidemiology	4	4	273
5	Health Informatics	1	1	42

Albert T.A. Mairuhu

Publications

2.2K

Citations

H-Index

Page 1

	Year	Citations
Simplified diagnostic management of suspected pulmonary embolism (the YEARS study): a prospective, multicentre, cohort study Tom van der Hulle, Whitney Cheung, Stephanie Kooij, The Lancet ThrombosisPulmonary EmbolismVenous ThrombosisCardiovascular DiseaseSimplified Diagnostic Management	2017	505
Pregnancy-Adapted YEARS Algorithm for Diagnosis of Suspected Pulmonary Embolism L.M. van der Pol, Cécile Tromeur, Ingrid M. Bistervels, New England Journal of Medicine	2019	322
Elevated plasma levels of the long pentraxin, pentraxin 3, in severe dengue virus infections Albert T.A. Mairuhu, Giuseppe Peri, Tatty E. Setiati, Journal of Medical Virology	2005	109
Non‐invasive diagnostic work‐up of patients with clinically suspected pulmonary embolism; results of a management study M. Ten Wolde, Petronella J. Hagen, M.R. Macgillavry, Journal of Thrombosis and Haemostasis ThrombosisPulmonary EmbolismVenous ThrombosisPatient SafetyDiagnosis	2004	82
Changes in the Plasma Lipid Profile as a Potential Predictor of Clinical Outcome in Dengue Hemorrhagic Fever Eric C. M. Van Gorp, Catharina Suharti, Albert T.A. Mairuhu, Clinical Infectious Diseases Lipid AnalysisPlasma Lipid ProfilePotential PredictorHyperlipidemiaArbovirus	2002	81
Population pharmacokinetics of lopinavir in combination with ritonavir in HIV‐1‐infected patients Kristel M. L. Crommentuyn, Bregt S Kappelhoff, Jan W. Mulder, British Journal of Clinical Pharmacology Ritonavir Plasma ConcentrationsPharmacotherapyPopulation PharmacokineticsAntiviral DrugPhysiologically-based Pharmacokinetic Modeling	2005	71
Changing epidemiology of dengue haemorrhagic fever in Indonesia Tatty E. Setiati, Jiri F. P. Wagenaar, Martijn D. de Kruif, Dengue DiseaseInfectious Disease EpidemiologyVector-borne PathogenMalariaInternational Health	2006	69
Non-invasive early exclusion of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: the InShape II study Gudula J.A.M. Boon, Yvonne M. Ende-Verhaar, Roisin Bavalia, Thorax	2021	69
Incidence and risk factors for nevirapine-associated rash Monique M. R. de Maat, Rob ter Heine, Jan W. Mulder, European Journal of Clinical Pharmacology Clinical EpidemiologyAntiviral TherapyAntiviral DrugPublic HealthRisk Factors	2003	68
The Plasma and Intracellular Steady-State Pharmacokinetics of Lopinavir/Ritonavir in HIV-1-Infected Patients Kristel M. L. Crommentuyn, Jan W. Mulder, Albert T.A. Mairuhu, Antiviral Therapy	2004	63

Page 1